EUVIMEDEUVIMED entdecken
Open Access

Manganese Dioxide-Based pH-Responsive Multifunctional Nanoparticles Deliver Methotrexate for Targeted Rheumatoid Arthritis Treatment

Jingwen Jia, Min Liu, Han Yang, XiaoFang Li, Siyi Liu, Kexin Li, Jiulong Zhang, Xiuli Zhao iD

Biomaterials Research · 2025-01 · 29

DOI: 10.34133/bmr.0187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 14.05.2025. Verfasst von Jingwen Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science Research Project of The Educational Department of Liaoning Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is an autoimmune disease characterized by hypoxia and reactive oxygen species (ROS) overexpression, which cause inflammatory cascade and cartilage erosion. As representative inflammatory cells, macrophages produce many inflammatory factors, and intracellular ROS is abnormally elevated. Therefore, improving hypoxia and scavenging ROS are essential to inhibit the inflammatory response of synovial macrophages and cartilage destruction. Due to the complex microenvironment of RA and the single action of most anti-inflammatory and antioxidant drugs, as well as the difficulty in reversing the microenvironment with current formulations developed for ROS clearance, it is necessary to develop multifunctional nanoparticles (NPs) to achieve better therapeutic effects. In this work, we constructed a delivery system called PCM@MnO 2 NPs, which could reduce inflammatory factors and improve the RA environment through multifunctional synergistic effects such as eliminating ROS and generating oxygen. Specifically, chondroitin sulfate was used to form NPs with methotrexate (MTX) through electrostatic interactions and hydrogen bonding and further loaded with MnO 2 to form CM@MnO 2 NPs. Furthermore, modification of polydopamine on the surface of CM@MnO 2 NPs improved the stability of the formulation and extended the cycle time. Under the acidic (pH 6.5) microenvironment of RA, polydopamine shells were dissociated. Chondroitin sulfate could target inflammatory macrophages via the CD44 receptor and subsequently release MTX and MnO 2 under low-intracellular-pH (pH 5.2) conditions. MnO 2 could decompose and consume ROS and further produce oxygen in the process of decomposing H 2 O 2 , alleviating the hypoxic microenvironment of RA. In addition, MTX could also inhibit the secretion of cytokines. Overall, by regulating the RA microenvironment through the various synergistic effects mentioned above, it could promote macrophage polarization and alleviate RA progression. The experimental results in vitro and in vivo indicated that pH-responsive PCM@MnO 2 NPs could accumulate in inflammatory joints by the extravasation through leaky vasculature and subsequent inflammatory cell-mediated sequestration (ELVIS) effect, enhance the precise delivery of MTX by targeting RA macrophages, and effectively alleviate the progression of disease and reduce the symptoms of collagen-induced arthritis mouse models. In general, using multifunctional synergistic therapy for RA is an effective potential strategy.

Autor:innen und Institutionen

  • College of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.

ORCID-Profile: Xiuli Zhao

Förderung

  • Science Research Project of The Educational Department of Liaoning Province

Zitieren

APA

Jia, J., Liu, M., Yang, H., Li, X., Liu, S., Li, K., Zhang, J., & Zhao, X. (2025). Manganese Dioxide-Based pH-Responsive Multifunctional Nanoparticles Deliver Methotrexate for Targeted Rheumatoid Arthritis Treatment. Biomaterials Research, 29. https://doi.org/10.34133/bmr.0187

Vancouver

Jia J, Liu M, Yang H, Li X, Liu S, Li K, et al. Manganese Dioxide-Based pH-Responsive Multifunctional Nanoparticles Deliver Methotrexate for Targeted Rheumatoid Arthritis Treatment. Biomaterials Research. 2025;29. doi:10.34133/bmr.0187

BibTeX
@article{Jia2025,
  author = {Jia, Jingwen and Liu, Min and Yang, Han and Li, XiaoFang and Liu, Siyi and Li, Kexin and Zhang, Jiulong and Zhao, Xiuli},
  title = {Manganese Dioxide-Based pH-Responsive Multifunctional Nanoparticles Deliver Methotrexate for Targeted Rheumatoid Arthritis Treatment},
  journal = {Biomaterials Research},
  year = {2025},
  volume = {29},
  doi = {10.34133/bmr.0187}
}
Kostenlos starten →